Table 13 Structured cardiac magnetic resonance examination reporting elements
Administrative | |
Recommended | Site of service Scanner field strength and model Procedure date and time Referring physician Referring clinical information, including indication(s) |
Optional | Laboratory accreditation status |
Patient demographics | |
Recommended | Unique patient identification number Date of birth Gender Height, weight, and body surface area |
Optional | Race and ethnicity Heart rate Blood pressure Renal function assessment |
Study performance | |
Recommended | Description of the study, including sequences Contrast agent, if any Sedation or anesthesia, if any Significant study limitations, if any Adverse events, if any |
Optional | Personnel involved in the procedure |
Structured cardiovascular findings | |
Recommended | Segmental diagnoses Ventricular volume, function, and mass assessment Regional wall motion assessment, if appropriate Late gadolinium enhancement, if appropriate |
Optional/as applicable | Significant non-cardiovascular findings, if any Key images |
Measurements | |
Recommended | Biventricular volume, function, and left ventricular mass measurements |
Optional/as applicable | Phase contrast flow measurements of the ascending aorta, main and branch pulmonary arteries Aortic measurements (with normal range as available) |
Summary of findings | |
Recommended | Abnormal findings Pertinent negative findings Comparison with previous studies, if appropriate |
Optional | Differential diagnoses Recommendations for further imaging |